<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02923427</url>
  </required_header>
  <id_info>
    <org_study_id>266-SBKAEK</org_study_id>
    <nct_id>NCT02923427</nct_id>
  </id_info>
  <brief_title>I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery</brief_title>
  <official_title>Comparison of I-gel and LMA Supreme Without Neuromuscular Blocker in Laparoscopic Gynecological Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dokuz Eylul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dokuz Eylul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effects of i-gel and Laryngeal mask airway Supreme (LMA-Supreme) on&#xD;
      ventilation parameters and surgical view during Trendelenburg Position laparoscopic&#xD;
      gynecological surgery in cases administered positive pressure ventilation without the use of&#xD;
      neuromuscular agents.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized and double-blind study, aged from 18 to 65 years undergoing elective&#xD;
      laparoscopic gynecological surgery.&#xD;
&#xD;
      The patients are randomly assigned to 2 groups:&#xD;
&#xD;
        -  Group 1: i-gel&#xD;
&#xD;
        -  Group 2: LMA- Supreme&#xD;
&#xD;
      Procedure:&#xD;
&#xD;
      The investigation protocol contains the following sections:&#xD;
&#xD;
        1. Induction of anaesthesia. For preoperative sedation 0.02 mg/kg midazolam IV will be&#xD;
           administered. 2 minutes of 0.2 µ/kg/min remifentanil and 6 mg kg st-1 propofol infusion,&#xD;
           IV 1-2 mg kg-1 propofol . No muscle relaxant will be used for insertion of the airway&#xD;
           device.&#xD;
&#xD;
        2. Bispectral index values will be held between 40-60.Bispectral index values will be&#xD;
           within this interval by increasing or decreasing propofol infusion by 1 mg/kg after&#xD;
           additional bolus dose of propofol (1 mg/kg).&#xD;
&#xD;
        3. Insertion of the airway device. The size of the airway device used is based on the&#xD;
           manufacturers' recommendations. All devices are deflated a lubricated prior to use. Once&#xD;
           inserted, the cuff is be inflated with a manometer up to 60 cm H20 Data recorded: size&#xD;
           of airway device, time an number of attempts.&#xD;
&#xD;
        4. Anesthesia maintenance will be ensured by 50% O2/air with 0.1-0.4 µ kg/min-1&#xD;
           remifentanil and 50-150 µ kg/ min-1 (4-10 mg/kg/hr) propofol IV infusion&#xD;
&#xD;
        5. Functionality of the gastric drainage channel of the airway device: passage of a 14 G&#xD;
           size tube.&#xD;
&#xD;
        6. Measurement of airway seal pressure (oropharyngeal leak pressure (OLP): at baseline, and&#xD;
           at 2 minutes after airway device insertion (T1), 10 minutes after insufflation (T2),&#xD;
           before desufflation (T3), before removal of airway device (T4). The maximum pressure&#xD;
           allowed is 40 cm H2O.&#xD;
&#xD;
        7. Ventilatory mechanics and parameters and hemodynamic parameters are measured at&#xD;
           baseline, and at T1, T2, T3 and T4.&#xD;
&#xD;
        8. Perioperative complications: Cough, vomiting, laryngeal spasm, laryngeal Stridor, airway&#xD;
           intervention requirements, hypoxia (SpO2 &lt; 92%)&#xD;
&#xD;
        9. Removal of the airway device: Presence of blood - 3 level grading (1:no blood; 2: trace&#xD;
           amounts of blood; 3: clear amounts of blood). Complications: sore throat ( VAS:10-point&#xD;
           scale), dysphonia (yes/no), dysphagia (yes/no).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Airway Seal Pressure Values</measure>
    <time_frame>At baseline and at 15, 30 and 60 minutes</time_frame>
    <description>This value is important as it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling. It is also used in LMA studies as an index of successful placement.Airway pressures of ≈20 cm H2O are typically required in routine practice.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Quality</measure>
    <time_frame>during pneumoperitoneum</time_frame>
    <description>quality of surgical view will evaluate by the scala. quality of surgical view will be assessed with points from 1 to 4 by the surgeon blind to the airway device; (1:best, 4: worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastric Tube Insertion</measure>
    <time_frame>following airway device insertion up to 5 minutes</time_frame>
    <description>Number of Participants According to Ease of Gastric Tube Insertion.Ease of passage of a gastric tube as: very easy, easy, difficult or very difficult.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pharyngolaryngeal Morbidity</measure>
    <time_frame>postoperative first hour and 24th hour</time_frame>
    <description>Sore throat evaluted by Visual Analogue Scale. The visual analog scale, also known as the graphic rating scale is a simple, valid and reliable subjective measure. Scores are ranked on a 10-cm line that stretches between two extremes - &quot;no pain&quot; and &quot;worst pain&quot;. Total range provided&quot;0 (no pain) to 10 (worst pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sufficiency of Pneumoperitoneum</measure>
    <time_frame>baseline</time_frame>
    <description>Number of Participants with Sufficiency of Pneumoperitoneum. Sufficiency of pneumoperitoneum for the surgical procedure according to surgeon, described as sufficient or insufficient questionaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Airway Pressure Values</measure>
    <time_frame>At baseline and at 15, 30 and 60 minutes</time_frame>
    <description>Mean airway pressure typically refers to the mean pressure applied during positive-pressure mechanical ventilation. Mean airway pressure correlates with alveolar ventilation, arterial oxygenation, hemodynamic performance, and barotrauma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dysphonia With Yes/no.</measure>
    <time_frame>postoperative first hour and 24th hour</time_frame>
    <description>We evaluated while a patient was talking with us that the patient has dysphonia or not .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disphagia</measure>
    <time_frame>postoperative first hour and 24th hour</time_frame>
    <description>We asked the question that you have a pain while you were swallowing, yes or not.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Airway Morbidity</condition>
  <condition>Anaesthesia</condition>
  <arm_group>
    <arm_group_label>Laryngeal mask Supreme</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>i-gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryngeal mask Supreme Evaluation</intervention_name>
    <description>Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
    <arm_group_label>Laryngeal mask Supreme</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>i-gel Evaluation</intervention_name>
    <description>Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
    <arm_group_label>i-gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. American Society of Anesthesiologists classification group I-II&#xD;
&#xD;
          2. between 18-65 years&#xD;
&#xD;
          3. undergoing elective laparoscopic gynecological surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Those with any neck or upper respiratory tract pathology&#xD;
&#xD;
          2. Those at risk of gastric content regurgitation/aspiration (previous upper&#xD;
             Gastrointestinal system surgery, known hiatus hernia, gastroesophageal reflux, history&#xD;
             of peptic ulcers, full stomach, pregnancy)&#xD;
&#xD;
          3. Those with low pulmonary compliance or high airway resistance (chronic pulmonary&#xD;
             diseases)&#xD;
&#xD;
          4. Obese patients (BMI &gt;35)&#xD;
&#xD;
          5. Those with throat pain, dysphagia and dysphonia&#xD;
&#xD;
          6. Those with possible or previous difficult airway&#xD;
&#xD;
          7. Those with operations planned for longer than 4 hours&#xD;
&#xD;
          8. Conversion to laparatomy&#xD;
&#xD;
          9. Neuromuscular blocking agent used&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferim Günenç, MD</last_name>
    <role>Study Director</role>
    <affiliation>Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation</name>
      <address>
        <city>İzmir</city>
        <zip>35340</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 22, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2016</study_first_posted>
  <results_first_submitted>December 21, 2017</results_first_submitted>
  <results_first_submitted_qc>September 12, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 8, 2020</results_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dokuz Eylul University</investigator_affiliation>
    <investigator_full_name>Sule Ozbilgin</investigator_full_name>
    <investigator_title>Dokuz Eylul University, MD, Anesthesiologists.</investigator_title>
  </responsible_party>
  <keyword>laryngeal mask Supreme</keyword>
  <keyword>i-gel</keyword>
  <keyword>laparoscopic gynecological surgery</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 21, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT02923427/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Laryngeal Mask Supreme</title>
          <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
        </group>
        <group group_id="P2">
          <title>I-gel</title>
          <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="57"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51">The reasons:&#xD;
n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed</participants>
                <participants group_id="P2" count="55">The reasons:&#xD;
n = 2 Convert to Laparotomy</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>convert to laparatomy</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>destaturation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>can not replace LMA</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Laryngeal Mask Supreme</title>
          <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
        </group>
        <group group_id="B2">
          <title>I-gel</title>
          <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="55"/>
            <count group_id="B3" value="106"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="51"/>
                    <count group_id="B2" value="55"/>
                    <count group_id="B3" value="106"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.55" spread="9.34"/>
                    <measurement group_id="B2" value="36.44" spread="8.31"/>
                    <measurement group_id="B3" value="35.49" spread="8.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="51"/>
                    <count group_id="B2" value="55"/>
                    <count group_id="B3" value="106"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="106"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Turkey</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="51"/>
                    <count group_id="B2" value="55"/>
                    <count group_id="B3" value="106"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Airway Seal Pressure Values</title>
        <description>This value is important as it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling. It is also used in LMA studies as an index of successful placement.Airway pressures of ≈20 cm H2O are typically required in routine practice.</description>
        <time_frame>At baseline and at 15, 30 and 60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Airway Seal Pressure Values</title>
          <description>This value is important as it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling. It is also used in LMA studies as an index of successful placement.Airway pressures of ≈20 cm H2O are typically required in routine practice.</description>
          <units>cm H2O</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.20" spread="8.07"/>
                    <measurement group_id="O2" value="27.58" spread="7.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.10" spread="6.48"/>
                    <measurement group_id="O2" value="28.76" spread="7.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.92" spread="6.19"/>
                    <measurement group_id="O2" value="28.71" spread="6.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.31" spread="6.19"/>
                    <measurement group_id="O2" value="29.13" spread="6.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Quality</title>
        <description>quality of surgical view will evaluate by the scala. quality of surgical view will be assessed with points from 1 to 4 by the surgeon blind to the airway device; (1:best, 4: worst).</description>
        <time_frame>during pneumoperitoneum</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Quality</title>
          <description>quality of surgical view will evaluate by the scala. quality of surgical view will be assessed with points from 1 to 4 by the surgeon blind to the airway device; (1:best, 4: worst).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.941" spread="0.42"/>
                    <measurement group_id="O2" value="3.945" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gastric Tube Insertion</title>
        <description>Number of Participants According to Ease of Gastric Tube Insertion.Ease of passage of a gastric tube as: very easy, easy, difficult or very difficult.</description>
        <time_frame>following airway device insertion up to 5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Gastric Tube Insertion</title>
          <description>Number of Participants According to Ease of Gastric Tube Insertion.Ease of passage of a gastric tube as: very easy, easy, difficult or very difficult.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>very easy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>easy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>very difficult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pharyngolaryngeal Morbidity</title>
        <description>Sore throat evaluted by Visual Analogue Scale. The visual analog scale, also known as the graphic rating scale is a simple, valid and reliable subjective measure. Scores are ranked on a 10-cm line that stretches between two extremes - &quot;no pain&quot; and &quot;worst pain&quot;. Total range provided&quot;0 (no pain) to 10 (worst pain).</description>
        <time_frame>postoperative first hour and 24th hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pharyngolaryngeal Morbidity</title>
          <description>Sore throat evaluted by Visual Analogue Scale. The visual analog scale, also known as the graphic rating scale is a simple, valid and reliable subjective measure. Scores are ranked on a 10-cm line that stretches between two extremes - &quot;no pain&quot; and &quot;worst pain&quot;. Total range provided&quot;0 (no pain) to 10 (worst pain).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>at first hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.43" spread="1.02"/>
                    <measurement group_id="O2" value="0.16" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24th hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.140"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sufficiency of Pneumoperitoneum</title>
        <description>Number of Participants with Sufficiency of Pneumoperitoneum. Sufficiency of pneumoperitoneum for the surgical procedure according to surgeon, described as sufficient or insufficient questionaire.</description>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Sufficiency of Pneumoperitoneum</title>
          <description>Number of Participants with Sufficiency of Pneumoperitoneum. Sufficiency of pneumoperitoneum for the surgical procedure according to surgeon, described as sufficient or insufficient questionaire.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>sufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>insufficient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Airway Pressure Values</title>
        <description>Mean airway pressure typically refers to the mean pressure applied during positive-pressure mechanical ventilation. Mean airway pressure correlates with alveolar ventilation, arterial oxygenation, hemodynamic performance, and barotrauma.</description>
        <time_frame>At baseline and at 15, 30 and 60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Airway Pressure Values</title>
          <description>Mean airway pressure typically refers to the mean pressure applied during positive-pressure mechanical ventilation. Mean airway pressure correlates with alveolar ventilation, arterial oxygenation, hemodynamic performance, and barotrauma.</description>
          <units>cm H2O</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.84" spread="0.92"/>
                    <measurement group_id="O2" value="5.82" spread="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 15 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.84" spread="1.23"/>
                    <measurement group_id="O2" value="7.87" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 30 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.45" spread="1.31"/>
                    <measurement group_id="O2" value="7.27" spread="1.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 60 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.51" spread="1.15"/>
                    <measurement group_id="O2" value="6.29" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dysphonia With Yes/no.</title>
        <description>We evaluated while a patient was talking with us that the patient has dysphonia or not .</description>
        <time_frame>postoperative first hour and 24th hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Dysphonia With Yes/no.</title>
          <description>We evaluated while a patient was talking with us that the patient has dysphonia or not .</description>
          <units>Number of Participants without Dysphonia</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>at first hour-no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 24th hour-no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disphagia</title>
        <description>We asked the question that you have a pain while you were swallowing, yes or not.</description>
        <time_frame>postoperative first hour and 24th hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Laryngeal Mask Supreme</title>
            <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
          </group>
          <group group_id="O2">
            <title>I-gel</title>
            <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
          </group>
        </group_list>
        <measure>
          <title>Disphagia</title>
          <description>We asked the question that you have a pain while you were swallowing, yes or not.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>at first hour-no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at 24th hour-no</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hour</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Laryngeal Mask Supreme</title>
          <description>Insertion of the &quot;Laryngeal mask Supreme&quot; and evaluation of its clinical performance&#xD;
Laryngeal mask Supreme Evaluation: Evaluation of clinical performance in terms of Insertion, ventilation and complications</description>
        </group>
        <group group_id="E2">
          <title>I-gel</title>
          <description>Insertion of the &quot;i-gel&quot; and evaluation of its clinical performance&#xD;
i-gel Evaluation: Evaluation of clinical performance in terms of Insertion,ventilation and complications</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Anaesthesiology and Intensive Care, Sule Ozbilgin</name_or_title>
      <organization>DorkuzEU</organization>
      <phone>905055252901</phone>
      <email>ozbilginsule@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

